Flecainide, Propafenone |
Issues for Surgery |
Risk of cardiac complications (i.e. bradycardia, hypotension, conduction disturbances and decreased cardiac output) if continued. Risk of QT-interval prolongation if flecainide is continued (see Interaction(s) with Common Anaesthetic Agents and Interaction(s) with other Common Medicines used in the Perioperative Period). |
Advice in the Perioperative period |
If patient is symptomatic (i.e. chest pain, palpitations, syncope, dyspnoea or new fatigue) and haemodynamically unstable discuss with a Cardiologist1. Check blood pressure, ECG, and potassium pre-operatively1, 2. Patients taking flecainide Post-operative Advice Patients taking flecainide` Monitor renal function post-operatively – renal impairment may result in flecainide accumulation2, 3. If patient develops systolic heart failure in the perioperative period consult with a Cardiologist1. |
Interaction(s) with Common Anaesthetic Agents |
Local Anaesthetics QT-Interval Prolongation (see also under Interaction(s) with other Common Medicines used in the Perioperative Period) Anaesthetic agents that may be used in the perioperative period that are known to, or predicted to, prolong the QT-interval include2, 5: -
*monitor ECG if concurrent use unavoidable; if risk factors for QT-prolongation are also present (increasing age, female sex, cardiac disease, and some metabolic disturbances e.g. hypokalaemia) use greater caution. **monitor ECG with concurrent use particularly if risk factors for QT-interval prolongation are also present (increasing age, female sex, cardiac disease, and some metabolic disturbances e.g. hypokalaemia). Antimuscarinic action |
Interaction(s) with other Common Medicines used in the Perioperative Period |
QT-Interval Prolongation (see also under Interaction(s) with Common Anaesthetic Agents) Medicines that may be used in the perioperative period that are known to prolong the QT-interval include2, 3, 5:-
*monitor ECG with concurrent use particularly if risk factors for QT-interval prolongation are also present (increasing age, female sex, cardiac disease, and some metabolic disturbances e.g. hypokalaemia). **monitor ECG if concurrent use avoidable; if risk factors for QT-prolongation are also present (increasing age, female sex, cardiac disease, and some metabolic disturbances e.g. hypokalaemia) use greater caution. Antimuscarinic action Nefopam Macrolides Whilst single surgical prophylactic doses should not pose a problem, continued post-operative treatment may require close monitoring. |
Further Information |
|
References |
|